PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Antidepressants may act in gut to reduce depression and anxiety

2024-12-11
(Press-News.org) NEW YORK, NY (Dec. 11, 2024)--Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue.

A new study in animals suggests that targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer cognitive, gastrointestinal, and behavioral side effects for patients and their children than current treatments.

“Antidepressants like Prozac and Zoloft that raise serotonin levels are important first-line treatments and help many patients but can sometimes cause side effects that patients can’t tolerate. Our study suggests that restricting the drugs to interact only with intestinal cells could avoid these issues,” says Mark Ansorge, associate professor of clinical neurobiology at Columbia University Vagelos College of Physicians and Surgeons, who co-led the study with Kara Margolis, Director of the NYU Pain Research Center and an associate professor of molecular pathobiology in the NYU College of Dentistry. 

For pregnant mothers, antidepressants that raise serotonin (called selective serotonin reuptake inhibitors, or SSRIs) present a unique problem, because the drugs cross the placenta and have been associated with mood, cognitive, and gastrointestinal problems later in childhood. 

“But not treating a pregnant person’s depression also comes with risks to their children,” Ansorge says. “An SSRI that selectively raises serotonin in the intestine could be a better alternative.”

How do SSRI antidepressants work?

For more than 30 years, SSRIs have been the first-line pharmacological treatments for anxiety and depression. They are also commonly prescribed to treat gastrointestinal issues that co-occur with these mood disorders. 

SSRIs boost serotonin signaling, and the drug’s effects on mood are thought to stem from increased serotonin signaling in the brain, where serotonin helps to relay messages.

Serotonin is also produced outside the brain, largely in cells that line the intestines. “In fact, 90% of our bodies’ serotonin is in the gut”, says Margolis, who is also an associate professor of pediatrics and cell biology at NYU Grossman School of Medicine.  SSRIs therefore increase serotonin signaling not just in the brain but also in the gut, raising the possibility that increasing serotonin signaling in the gut may impact gut-brain communication and ultimately mood. 

The researchers tested this possibility in mice using a combination of genetic engineering, surgery, and pharmaceuticals.

Increasing intestinal serotonin reduces anxiety, depressive behaviors in mice

To determine if targeting serotonin in the gut can affect mood, the researchers engineered mice to amplify serotonin signaling in the gut—which mimicked an SSRI delivered selectively to the gut. They found that animals with increased serotonin signaling in the gut displayed fewer anxiety and depressive-like behaviors than their unaffected littermates. 

“These results suggest that SSRIs produce therapeutic effects by working directly in the gut,” Ansorge says. 

The animals also displayed none of the cognitive or gastrointestinal side effects commonly seen in patients taking SSRIs or in mice with increased serotonin signaling throughout their entire bodies. 

“Based on what we know about interactions between the brain and gut, we expected to see some effect. But to see enhanced serotonin signaling in the gut epithelium produce such robust antidepressant and anxiety-relieving effects without noticeable side effects was surprising even to us,” Ansorge says.

“There may be an advantage to targeting antidepressants selectively to the gut epithelium,” adds Margolis. “Systemic treatment may not be necessary for eliciting the drugs’ benefits.”

The researchers also found that the vagus nerve was necessary for the gut’s antidepressant and anxiety-relieving effects. The vagus nerve has long been known for its critical role in brain/gut communication, but mostly for top-down communication from the brain to the gut. Here the researchers found the other direction to be critical, with vagus nerve signaling from the gut to the brain. 

A better antidepressant option during pregnancy?

SSRI treatment poses challenges in pregnancy, because some studies have found that exposure in utero may negatively affect the development of mood, behavior, and cognition later in childhood. Ansorge’s previous research in animals has found similar results, identifying behavioral changes in offspring exposed only briefly to SSRIs during development.

The new study adds to the evidence that in utero exposure to serotonin-targeting antidepressants has negative effects on children. The researchers looked at more than 400 mothers and babies and found that children exposed to such antidepressants were 3 times more likely to develop constipation in their first year of life.

Ansorge and Margolis caution that pregnant people currently taking SSRIs should not discontinue their treatment based on these and other findings. “Maternal depression and anxiety can have many unwanted effects on fetal and child development and must thus be treated and monitored adequately to the benefit of both mother and child,” says Ansorge.

The researchers are now working to develop a selective SSRI that targets the gut, which could be a better option for treating depression and anxiety especially in pregnant women. 

“Our findings indicate that we may be able to treat a mother’s depression or anxiety effectively without exposing the child,” Ansorge says, “and we are working on drug delivery technology that will hopefully help us achieve that.”

Additional information

The study, titled "Intestinal Epithelial Serotonin as a Novel Target for Trearting Disorders of the Gut-Brain Interaction and Mood," was was published Dec. 11 in the journal Gastroenterology.

All authors: Lin Y. Hung (New York University), Nuno D. Alves (Columbia), Andrew Del Colle (NYU), Ardesheer Talati (Columbia), Sarah A. Najjar (NYU), Virginie Bouchard (Université de Sherbrooke), Virginie Gillet (Sherbrooke), Yan Tong (NYU), Zixing Huang (NYU), Kirsteen N. Browning (Penn State), Jialiang Hua (Columbia), Ying Liu (Columbia), James O. Woodruff (Columbia), Daniel Juarez (NYU), Melissa Medina (NYU), Jonathan Posner (Duke University), Raquel Tonello (NYU), Nazli Yalcinkaya (Baylor), Narek Israelyan (NYU), Roey Ringel (NYU), Letao Yang (Columbia), Kam W Leong (Columbia), Mu Yang (Columbia), Ji Ying Sze (Albert Einstein College of Medicine), Tor Savidge (Baylor), Jay Gingrich (Columbia), Robert J. Shulman (Baylor), Michael D Gershon (Columbia), Annie Ouellet (Sherbrooke), Larissa Takser (Sherbrooke), Mark S. Ansorge (Columbia), and Kara Gross Margolis (NYU).

###

Columbia University Irving Medical Center (CUIMC) is a clinical, research, and educational campus located in New York City. Founded in 1928, CUIMC was one of the first academic medical centers established in the United States of America. CUIMC is home to four professional colleges and schools that provide global leadership in scientific research, health and medical education, and patient care including the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing. For more information, please visit cuimc.columbia.edu. 

 

END



ELSE PRESS RELEASES FROM THIS DATE:

New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer

2024-12-11
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer. The trial, which is the first to open through the newly formed National Cancer Institute (NCI) Clinical Trials Innovation Unit (CTIU), aims to evaluate the role of immunotherapy before and after surgery in patients with non-small cell lung cancer. The PROSPECT-Lung trial is a large, multicenter trial developed and led by the Alliance for Clinical Trials in Oncology and the SWOG Cancer Research Network and conducted within the NIH-funded NCI National Clinical Trials Network (NCTN), ...

The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions

The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions
2024-12-11
The Welch Foundation, one of the nation’s leading private funders of basic chemistry research, has awarded the 2025 Norman Hackerman Award in Chemical Research to Haotian Wang, an associate professor in the Department of Chemical and Biomolecular Engineering at Rice University. Wang is recognized for his groundbreaking contributions to carbon dioxide electrochemistry, which pave the way for sustainable energy solutions. Wang’s innovative research focuses on harnessing the catalyst-electrolyte ...

Hospital payment caps could save millions of dollars for state employee health plans

2024-12-11
PROVIDENCE, R.I. [Brown University] — State employee health plans could have saved $7.1 billion nationwide by capping hospital payments at 200% of Medicare rates in 2022, a study led by researchers at the Brown University School of Public Health found. “States are under growing budgetary pressure due to rising health care spending, primarily through increases in hospital and drug prices,” said study author Roslyn Murray, an assistant professor of health services, policy and practice ...

Intraarterial radionuclide therapy safe and effective for advanced meningioma patients

Intraarterial radionuclide therapy safe and effective for advanced meningioma patients
2024-12-11
Reston, VA (December 10, 2024)—Radionuclide therapy delivered directly to an artery is safe and feasible for patients with advanced meningioma, according to new research published in the December issue of The Journal of Nuclear Medicine. In the first long-term study of intraarterial peptide receptor radionuclide therapy (PRRT) in advanced meningioma, patients saw improved radiologic and clinical disease control compared with intravenous PRRT, with no additional toxicity. Meningiomas are the most common primary neoplasms of the central nervous system and account for more than one-third of all cases. Meningiomas are mostly ...

University of Tennessee and Sheffield sign MOU to facilitate collaborations

University of Tennessee and Sheffield sign MOU to facilitate collaborations
2024-12-11
The University of Tennessee and the University of Sheffield recently signed a memorandum of understanding to facilitate educational and research collaborations, share best practices, and promote student and staff exchanges between the institutions.   Tickle College of Engineering Dean Matthew Mench, the Wayne T. Davis Dean’s Chair, traveled to England in late November to tour the Sheffield facilities, meet with faculty, and sign the MOU with Malcolm Butler, the vice president and director of global engagement of the University of Sheffield.  There ...

Nemours Children’s Health Initiative to start HPV vaccination at age 9 improved completion rates

2024-12-11
WILMINGTON, Del. (December 11, 2024) — A quality improvement program designed to increase earlier uptake of the human papillomavirus (HPV) vaccine raised vaccination rates significantly, according to a study by Nemours Children’s Health researchers. In a new study published in Academic Pediatrics, Caitlin J. Miller, medical student at Sidney Kimmel Medical College of Thomas Jefferson University and Jonathan Miller, MD, Associate Chief of Primary Care, Nemours Children’s ...

Nova SBE and New York University Tandon School of Engineering launch transatlantic dual degree program

2024-12-11
Nova School of Business and Economics (Nova SBE) has partnered with NYU Tandon School of Engineering  to  create a transatlantic program focusing on two strategic and complementary fields: Management (Nova SBE) and Management of Technology (NYU Tandon). This new program allows students to earn distinct master’s degrees from two of the world’s most prestigious academic institutions, located in key cultural and economic centers: Lisbon and New York.  Under this partnership agreement, students enrolled in either the International Master’s in Management or the Master’s in Management (both from Nova SBE) ...

2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship awarded to Morgan Fogarty

2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship awarded to Morgan Fogarty
2024-12-11
BELLINGHAM, Washington, USA — SPIE, the international society for optics and photonics, has announced Morgan Fogarty, who is expected to receive her PhD in Imaging Science from Washington University in St. Louis (WashU) in February, as the recipient of the 2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics. The annual award of $75,000 supports interdisciplinary problem-driven research and provides opportunities for translating new technologies ...

Grants expand roadway safety programs to Native American youth and older drivers

Grants expand roadway safety programs to Native American youth and older drivers
2024-12-11
The National Highway Traffic Safety Administration (NHTSA) estimates that in 2023 a staggering 40,990 people died from motor vehicle crashes in the United States, reflecting some of the highest numbers seen in nearly two decades. The Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego is creating programs to improve safety for all roadway users, including drivers, pedestrians and cyclists. With support from two grants from the California Office of Traffic Safety (OTS) through the NHTSA, the school is developing an educational program geared towards Native American youth as well as new online courses to improve ...

Database documents sex differences in cancer biology, risk, and treatment

2024-12-11
A groundbreaking new database could lead to vast improvements in precision oncology by documenting sex-based differences in cancer treatment efficacy, biomarkers, risk factors, and microbial influences across 71 cancer types. The database — created by researchers at the Yale School of Public Health (YSPH), Yale School of Medicine (YSM), and international collaborators — addresses a significant gap in current research and demonstrates how biological sex can comprehensively impact cancer onset, progression, and therapeutic outcomes, the researchers said. The ...

LAST 30 PRESS RELEASES:

New study reveals how reduced rainfall threatens plant diversity

New study reveals optimized in vitro fertilization techniques to boost coral restoration efforts in the Caribbean

No evidence that maternal sickness during pregnancy causes autism

Healthy gut bacteria that feed on sugar analyzed for the first time

240-year-old drug could save UK National Health Service £100 million a year treating common heart rhythm disorder

Detections of poliovirus in sewage samples require enhanced routine and catch-up vaccination and increased surveillance, according to ECDC report

Scientists unlock ice-repelling secrets of polar bear fur for sustainable anti-freezing solutions 

Ear muscle we thought humans didn’t use — except for wiggling our ears — actually activates when people listen hard

COVID-19 pandemic drove significant rise in patients choosing to leave ERs before medically recommended

Burn grasslands to maintain them: What is good for biodiversity?

Ventilation in hospitals could cause viruses to spread further

New study finds high concentrations of plastics in the placentae of infants born prematurely

New robotic surgical systems revolutionizing patient care

New MSK research a step toward off-the-shelf CAR T cell therapy for cancer

UTEP professor wins prestigious research award from American Psychological Association

New national study finds homicide and suicide is the #1 cause of maternal death in the U.S.

Women’s pelvic tissue tears during childbirth unstudied, until now

Earth scientists study Sikkim flood in India to help others prepare for similar disasters

Leveraging data to improve health equity and care

Why you shouldn’t scratch an itchy rash: New study explains

Linking citation and retraction data aids in responsible research evaluation

Antibody treatment prevents severe bird flu in monkeys

Polar bear energetic model reveals drivers of polar bear population decline

Socioeconomic and political stability bolstered wild tiger recovery in India

Scratching an itch promotes antibacterial inflammation

Drivers, causes and impacts of the 2023 Sikkim flood in India

Most engineered human cells created for studying disease

Polar bear population decline the direct result of extended ‘energy deficit’ due to lack of food

Lifecycle Journal launches: A new vision for scholarly publishing

Ancient DNA analyses bring to life the 11,000-year intertwined genomic history of sheep and humans

[Press-News.org] Antidepressants may act in gut to reduce depression and anxiety